专利检索 ap:"Pierre Renard" 第 1 页

1.

发明申请
Isoquinoline compounds 审中-公开
标题翻译：异喹啉化合物

公开(公告)号：US20070191328A1

公开(公告)日：2007-08-16

申请号：US11725855

申请日：2007-03-20

申请人： Sophie Poissonnier-Durieux , Valerie Wallez , Anne Gasnereau , Said Yous , Daniel Lesieur , Philippe Delagrange , Pierre Renard , Caroline Bennejean , Jean Boutin , Valerie Audinot

发明人： Sophie Poissonnier-Durieux , Valerie Wallez , Anne Gasnereau , Said Yous , Daniel Lesieur , Philippe Delagrange , Pierre Renard , Caroline Bennejean , Jean Boutin , Valerie Audinot

IPC分类号： A61K31/33

CPC分类号： C07D217/16

摘要： The invention relatests compound of formula (I): wherein: n is 1, 2 or 3, A represents a group or a group X represents N or NR1, R2 represents an alkoxy, cycloalkyloxy or cycloalkylalkyloxy group. and medicinal products containing the same which are useful in treading or in preventing melatoninergic disorder.

摘要翻译： 本发明涉及式（I）化合物：其中：n为1,2或3，A代表基团或基团X表示N或NR 1，R 2，表示烷氧基，环烷氧基或环烷基烷氧基。和含有它们的药用产品，其可用于踩踏或预防褪黑激素障碍。

2.

发明申请
Thiadiazine derivatives and use thereof as positive ampa receptor modulators 失效
标题翻译：噻二嗪衍生物及其作为正安培受体调节剂的用途

公开(公告)号：US20070004709A1

公开(公告)日：2007-01-04

申请号：US10555743

申请日：2004-05-04

申请人： Pierre Francotte , Stephane Boverie , Pascal De Tullio , Bernard Pirotte , Pierre Lestage , Laurence Danober , Pierre Renard , Daniel-Henri Caignard

发明人： Pierre Francotte , Stephane Boverie , Pascal De Tullio , Bernard Pirotte , Pierre Lestage , Laurence Danober , Pierre Renard , Daniel-Henri Caignard

IPC分类号： A61K31/549 , C07D498/02

CPC分类号： C07D513/04

摘要： Compounds of formula (I): wherein: A represents thienyl, furyl, pyrrolyl, oxathiol, thiazole, isothiazole, oxazole or imidazole, represents a single bond or a double bond, R1 represents hydrogen, linear or branched (C1-C6)alkyl optionally substituted by one or more groups selected from halogen or (C1-C6)alkoxy-(C1-C6)alkyl, R2 represents hydrogen or linear or branched (C1-C6)alkyl group optionally substituted by one or more halogen, R3 represents hydrogen or a group selected from linear or branched (C1-C6)alkyl, CONHR′ and SO2NHR′ wherein R′ represents linear or branched (C1-C6)alkyl, its enantiomers and diastereoisomers, and addition salts thereof with a pharmaceutically acceptable acid or base. Medicinal products containing the same, which are useful as AMPA inhibitors.

摘要翻译： 式（I）化合物：其中：A表示噻吩基，呋喃基，吡咯基，氧硫杂环戊烷，噻唑，异噻唑，恶唑或咪唑，表示单键或双键，R <1 表示任选被一个或多个选自卤素或（C 1 -C 6）烷基的基团取代的直链或支链（C 1 -C 6 -C 6）烷基， -C 6 -C 6烷氧基 - （C 1 -C 6 -C 6）烷基，R 2表示氢或直链或任选被一个或多个卤素取代的支链（C 1 -C 6 -C 6）烷基，R 3 3表示氢或选自直链或支链（C 1 -C 6 -C 6）烷基，CONHR'和SO 2 NHR'，其中R'表示直链或支链（C 1 -C 6） 1 -C 6烷基，其对映体和非对映异构体及其加成盐w 具有药学上可接受的酸或碱。含有该药物的药物，可用作AMPA抑制剂。

3.

发明授权
Heterocyclic oxime compounds 失效
标题翻译：杂环肟化合物

公开(公告)号：US07071221B2

公开(公告)日：2006-07-04

申请号：US10902345

申请日：2004-07-29

申请人： Véronique Leclerc , Sylvie Pailloux , Pascal Carato , Carine Introvigne , Nicolas Lebegue , Pascal Berthelot , Catherine Dacquet , Jean Albert Boutin , Daniel Henri Caignard , Pierre Renard

发明人： Véronique Leclerc , Sylvie Pailloux , Pascal Carato , Carine Introvigne , Nicolas Lebegue , Pascal Berthelot , Catherine Dacquet , Jean Albert Boutin , Daniel Henri Caignard , Pierre Renard

IPC分类号： A61K31/428 , A61K31/423 , C07D277/68 , C07D263/58

CPC分类号： C07D277/68 , C07D417/10

摘要： Compounds of formula (I): wherein: X represents oxygen or sulphur or a group CH2 or R1, R2, R3, R4, R5 and R6 are as defined in the description, A represents an alkylene chain as defined in the description, B represents alkyl or alkenyl substituted by a group or R9, or B represents a group or R9, D represents a benzene, pyridine, pyrazine, pyrimidine or pyridazine nucleus. Medicaments

摘要翻译： 式（I）化合物：其中：X表示氧或硫或CH 2或R 1，R 2，R 2， R 3，R 4，R 5和R 6如说明书中所定义，A代表如所定义的亚烷基链在说明书中，B表示被基团或R 9取代的烷基或链烯基，或B表示基团或R 9，D表示苯，吡啶，吡嗪，嘧啶或哒嗪核。药剂

4.

发明申请
Phenylnaphthalene compounds 审中-公开
标题翻译：苯基萘化合物

公开(公告)号：US20060106111A1

公开(公告)日：2006-05-18

申请号：US10534116

申请日：2003-11-04

申请人： Sophie Poissonnier-Durieux , Said Yous , Daniel Lesieur , Caroline Bennejean , Philippe Delagrange , Pierre Renard

发明人： Sophie Poissonnier-Durieux , Said Yous , Daniel Lesieur , Caroline Bennejean , Philippe Delagrange , Pierre Renard

IPC分类号： A61K31/17 , A61K31/165

CPC分类号： C07D207/27 , C07C233/18 , C07C233/36 , C07C233/60 , C07C2601/04

摘要： The invention relates to compounds of formula (I): wherein: A represents R3 represents alkoxy, R4 is as defined in the description, p is 1, 2 or 3, and medicinal products containing the same which are useful in treating or preventing melatoninergic disorders.

摘要翻译： 本发明涉及式（I）的化合物：其中：A表示R 3表示烷氧基，R 4如描述中所定义，p为1,2或3 和含有该药物的药物，其可用于治疗或预防褪黑激素障碍。

5.

发明授权
Method for making an anisotropic conductive polymer film on a semiconductor wafer 失效
标题翻译：在半导体晶片上制造各向异性导电聚合物膜的方法

公开(公告)号：US07026239B2

公开(公告)日：2006-04-11

申请号：US10488939

申请日：2003-07-22

申请人： Jean-Charles Souriau , Pierre Renard , Jean Brun

发明人： Jean-Charles Souriau , Pierre Renard , Jean Brun

IPC分类号： H01L21/4763

CPC分类号： H01L23/5328 , H01L21/2885 , H01L21/6835 , H01L21/76885 , H01L24/11 , H01L24/13 , H01L24/29 , H01L24/83 , H01L2221/68345 , H01L2221/68359 , H01L2224/05568 , H01L2224/05573 , H01L2224/13099 , H01L2224/29111 , H01L2224/2919 , H01L2224/83101 , H01L2224/8319 , H01L2224/838 , H01L2924/0001 , H01L2924/00014 , H01L2924/01005 , H01L2924/01006 , H01L2924/01013 , H01L2924/01022 , H01L2924/01024 , H01L2924/01029 , H01L2924/01047 , H01L2924/01057 , H01L2924/01058 , H01L2924/01059 , H01L2924/01061 , H01L2924/01073 , H01L2924/01074 , H01L2924/01079 , H01L2924/0132 , H01L2924/0781 , H01L2924/12044 , H01L2924/14 , H01L2924/30107 , H01L2924/0105 , H01L2924/01082 , H01L2224/05599

摘要： A method of manufacturing an anisotropic conductive polymer film on a semiconductor wafer including on one surface a layer of passivation in which at least one opening is made to allow access to a contact pad. The method can be applied to creating components (chips, integrated circuits) with high-density interconnections.

摘要翻译： 一种在半导体晶片上制造各向异性导电聚合物膜的方法，包括在一个表面上具有至少一个开口以允许接触接触垫的钝化层。该方法可用于创建具有高密度互连的组件（芯片，集成电路）。

6.

发明申请
Imidazopyridine derivatives, preparation method and pharmaceutical compositions containing same 失效
标题翻译：咪唑并吡啶衍生物，制备方法和含有其的药物组合物

公开(公告)号：US20060069117A1

公开(公告)日：2006-03-30

申请号：US10533699

申请日：2003-11-04

申请人： Sylvain Rault , Jean-Charles Lancelot , Marina Kopp , Daniel-Henri Caignard , Bruno Pfeiffer , Jean-Guy Bizot-Espiard , Pierre Renard

发明人： Sylvain Rault , Jean-Charles Lancelot , Marina Kopp , Daniel-Henri Caignard , Bruno Pfeiffer , Jean-Guy Bizot-Espiard , Pierre Renard

IPC分类号： C07D471/02 , A61K31/4745

CPC分类号： C07D471/04

摘要： Compounds of formula (I): wherein: R1 represents hydrogen, halogen, alkyl, polyhaloalkyl, cyano, nitro, hydroxycarbonyl, alkoxycarbonyl, aminocarbonyl, alkylaminocarbonyl or dialkylaminocarbonyl, R2 represents hydrogen, alkyl, an optionally substituted aryl, optionally substituted heteroaryl, or R20—C(X)— wherein: R20 represents alkyl, alkoxy, amino, alkylamino, dialkylamino, optionally substituted aryl or optionally substituted heteroaryl, X represents oxygen, sulphur, or NR21 wherein R21 represents hydrogen or alkyl, R3 represents hydrogen atom or alkyl, n represents integer from 1 to 6 inclusive, the representation its enantiomers, diastereoisomers and also addition salts thereof with a pharmaceutically acceptable acid or base, and medicinal products containing the same which are useful as AMPK activators.

摘要翻译： 式（I）的化合物：

7.

发明申请
Novel substituted [1,4] benzodioxino[2,3-e] isoindole derivatives, method for preparing and pharmaceutical compositions containing same 失效
标题翻译：新型取代的[1,4]苯并二氧杂环己二烯并[2,3-e]异吲哚衍生物，制备方法和含有它们的药物组合物

公开(公告)号：US20060040930A1

公开(公告)日：2006-02-23

申请号：US10531393

申请日：2003-10-17

申请人： Gerard Coudert , Nathalie Ayerbe , Franck Lepiere , Sylvain Routier , Daniel-Henri Caignard , Pierre Renard , John Hickman , Alain Pierre , Stephane Leonce

发明人： Gerard Coudert , Nathalie Ayerbe , Franck Lepiere , Sylvain Routier , Daniel-Henri Caignard , Pierre Renard , John Hickman , Alain Pierre , Stephane Leonce

IPC分类号： A61K31/5383 , A61K31/4745 , C07D491/14 , C07D471/14

CPC分类号： C07D471/14 , C07D487/04 , C07D491/14

摘要： Compounds of formula (I): wherein: A is as defined in the description, Y represents a group selected from an oxygen atom and a methylene group, R2 represents a hydrogen atom and in that case: R3 represents a group selected from a hydrogen atom and the groups linear or branched (C1-C6)alkyl, aryl, aryl-(C1-C6)alkyl (in which the alkyl moiety is linear or branched) and SO2CF3, or R2 and R3 form a bond, R1 represents a group selected from a hydrogen atom and the groups linear or branched (C1-C6)alkyl, aryl and aryl-(C1-C6)alkyl (in which the alkyl moiety is linear or branched) or a linear or branched (C1-C6)alkylene chain, Z1 and Z2 each represent a hydrogen atom or Z1 and Z2, together with the carbon atoms carrying them, form a phenyl group. Medicaments.

摘要翻译： 式（I）的化合物：其中：A如说明书中所定义，Y表示选自氧原子和亚甲基的基团，R 2表示氢原子，在这种情况下：R 3 表示选自氢原子和直链或支链（C 1 -C 6 -C 6）烷基，芳基，芳基 - （ C 1 -C 6 -C 6烷基（其中烷基部分是直链或支链的）和SO 2 -C 3 C 3 >或R 2和R 3'形成键，R 1表示选自氢原子和直链或支链基团的基团（ C 1 -C 6 -C 6烷基，芳基和芳基 - （C 1 -C 6 -C 6）烷基（在其中烷基部分是直链或支链的）或直链或支链（C 1 -C 6 -C 6）亚烷基链，Z 1和Z 2，各自表示氢原子或Z 1和Z 2，以及带有它们的碳原子形成苯基。药剂

8.

发明申请
Imidazoline compounds 审中-公开
标题翻译：咪唑啉化合物

公开(公告)号：US20050143440A1

公开(公告)日：2005-06-30

申请号：US11069094

申请日：2005-03-01

申请人： Sylvain Rault , Marina Kopp , Jean-Charles Lancelot , Stephane Lemaitre , Daniel-Henri Caignard , Jean-Guy Bizot-Espiard , Pierre Renard

发明人： Sylvain Rault , Marina Kopp , Jean-Charles Lancelot , Stephane Lemaitre , Daniel-Henri Caignard , Jean-Guy Bizot-Espiard , Pierre Renard

IPC分类号： A61K31/381 , A61K31/402 , A61K31/417 , A61K31/4178 , A61K31/44 , A61K31/4439 , A61P3/00 , A61P3/04 , A61P3/06 , A61P3/10 , A61P9/00 , A61P9/10 , C07D401/06 , C07D403/06 , C07D409/06 , A61K31/4164

CPC分类号： C07D401/06 , C07D403/06 , C07D409/06

摘要： Compounds of formula (I): wherein: R1 represents an optionally substituted heteroaryl group, R2 represents an optionally substituted cycloalkyl group, R3 represents a hydrogen atom or an alkyl group, and R4 and R5 are as defined in the description, and Medicinal products containing the same are useful in the treatment of non-insulin-dependent type II diabetes, obesity, type I diabetes, hyperlipidaemia, hypercholesterolaemia and cardiovascular complications thereof.

摘要翻译： 式（I）化合物：其中：R 1表示任选取代的杂芳基，R 2表示任选取代的环烷基，R 3，表示氢原子或烷基，R 4和R 5和R 5如说明书中所定义，并且含有它们的药用产品可用于治疗非 - 胰岛素依赖型II型糖尿病，肥胖症，I型糖尿病，高脂血症，高胆固醇血症及其心血管并发症。